Business Context and Reporting Period
Company: Organigram Holdings Inc. (Foreign Private Issuer)
Filing Type: Form 6-K
Reporting Period: March 2025 (Specifically March 24, 2025)
Principal Executive Offices: Toronto, Ontario, Canada
This filing serves as a report of current events pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The registrant files annual reports under Form 40-F.
Key Financial Metrics
The provided filing text does not contain specific financial data. It is a cover document referencing exhibits rather than a financial statement.
- Revenue: Not provided in filing text.
- Profit: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not explicitly detail material changes in financial performance or operations. It indicates the submission of two specific exhibits:
- Exhibit 99.1: News Release dated March 24, 2025.
- Exhibit 99.2: Report on Voting Results dated March 24, 2025.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These items are likely contained within the referenced News Release (Exhibit 99.1) or Voting Results (Exhibit 99.2), which are not included in the input text.
Investor Verification Checklist
- Review Exhibit 99.1 (News Release) for the specific content of the announcement made on March 24, 2025.
- Review Exhibit 99.2 (Voting Results) to understand the outcome of the shareholder vote referenced in this filing.
- Verify if the "News Release" contains updated financial guidance or material operational changes not summarized in this cover sheet.
- Confirm the company's status as a Form 40-F filer for future annual reporting expectations.